AFSSAPS loses patience with implants firm:
This article was originally published in Clinica
The French healthcare products safety agency, AFSSAPS, has issued a decision banning the further sale and use of a series of medical implantables manufactured by French company, Proconcept, for orthopaedic surgery. The CE marking certificates had expired on the products in February, a fact drawn to the attention of the agency by Proconcept's notified body, TUV Rheinland Product Safety (Germany). The French national society for certification and registration had also mentioned the expired certificate to the French authorities. Despite a series of warnings, the company has not responded to the French authorities. Therefore, the distribution, export and use of the LIFEC lumbar cage, the CIFEC cervical cage, the SRE/SEO lumbar screw systems and the Canaletto carpian canal protectors are banned for all products that were manufactured between February 16 and June 9 2005, bearing the label reference 0197 TUV Rheinland notified body number.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.